NO963460L - Farmasöytisk preparat inneholdende plasminogenaktivatorer - Google Patents

Farmasöytisk preparat inneholdende plasminogenaktivatorer

Info

Publication number
NO963460L
NO963460L NO963460A NO963460A NO963460L NO 963460 L NO963460 L NO 963460L NO 963460 A NO963460 A NO 963460A NO 963460 A NO963460 A NO 963460A NO 963460 L NO963460 L NO 963460L
Authority
NO
Norway
Prior art keywords
pct
plasminogen activators
pharmaceutical preparation
preparation containing
containing plasminogen
Prior art date
Application number
NO963460A
Other languages
English (en)
Other versions
NO963460D0 (no
NO317726B1 (no
Inventor
Ulrich Kohnert
Stephan Fischer
Hans-Jorg Markl
Heinrich Woog
Original Assignee
Actavis Group Ptc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Ptc filed Critical Actavis Group Ptc
Publication of NO963460D0 publication Critical patent/NO963460D0/no
Publication of NO963460L publication Critical patent/NO963460L/no
Publication of NO317726B1 publication Critical patent/NO317726B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19963460A 1994-02-21 1996-08-20 Farmasoytisk preparat av en plasminogenaktivator, fremgangsmate for fremstilling av preparatet, anvendelse av en kombinasjon av farmasoytiske hjelpestoffer til fremstilling av farmasoytiske administreringsformer og til langtidsstabilisering av farmasoytiske administreringsformer. NO317726B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4405426A DE4405426A1 (de) 1994-02-21 1994-02-21 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
PCT/EP1995/000596 WO1995022347A1 (de) 1994-02-21 1995-02-18 Pharmazeutisches präparat enthaltend plasminogenaktivatoren

Publications (3)

Publication Number Publication Date
NO963460D0 NO963460D0 (no) 1996-08-20
NO963460L true NO963460L (no) 1996-10-18
NO317726B1 NO317726B1 (no) 2004-12-13

Family

ID=6510724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963460A NO317726B1 (no) 1994-02-21 1996-08-20 Farmasoytisk preparat av en plasminogenaktivator, fremgangsmate for fremstilling av preparatet, anvendelse av en kombinasjon av farmasoytiske hjelpestoffer til fremstilling av farmasoytiske administreringsformer og til langtidsstabilisering av farmasoytiske administreringsformer.

Country Status (26)

Country Link
US (1) US5747030A (no)
EP (1) EP0746334B1 (no)
JP (1) JP3868997B2 (no)
KR (1) KR100356934B1 (no)
CN (1) CN1170591C (no)
AT (1) ATE205091T1 (no)
AU (1) AU691881B2 (no)
BR (1) BR9506840A (no)
CA (1) CA2183755C (no)
CZ (1) CZ286682B6 (no)
DE (2) DE4405426A1 (no)
DK (1) DK0746334T3 (no)
ES (1) ES2162913T3 (no)
FI (1) FI117925B (no)
HU (1) HU219769B (no)
MX (1) MX9603515A (no)
NO (1) NO317726B1 (no)
NZ (1) NZ281607A (no)
PL (1) PL181257B1 (no)
PT (1) PT746334E (no)
RU (1) RU2155067C2 (no)
SG (1) SG50567A1 (no)
SK (1) SK282827B6 (no)
TW (1) TW337997B (no)
WO (1) WO1995022347A1 (no)
ZA (1) ZA951371B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US20050025825A1 (en) * 2003-07-31 2005-02-03 Xanodyne Pharmacal, Inc. Tranexamic acid formulations with reduced adverse effects
US20090214644A1 (en) * 2003-07-31 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations with reduced adverse effects
US7947739B2 (en) 2004-03-04 2011-05-24 Ferring B.V. Tranexamic acid formulations
US20090215898A1 (en) * 2004-03-04 2009-08-27 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US20050244495A1 (en) 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US8022106B2 (en) * 2004-03-04 2011-09-20 Ferring B.V. Tranexamic acid formulations
US20050245614A1 (en) * 2004-03-04 2005-11-03 Xanodyne Pharmaceuticals, Inc. Tranexamic acid formulations
US9309316B2 (en) 2005-12-20 2016-04-12 Bristol-Myers Squibb Company Stable subcutaneous protein formulations and uses thereof
US8476239B2 (en) 2005-12-20 2013-07-02 Bristol-Myers Squibb Company Stable protein formulations
US20100280117A1 (en) * 2009-04-30 2010-11-04 Xanodyne Pharmaceuticals, Inc. Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
WO2014144549A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Factor ix polypeptide formulations
AU2015236340B2 (en) * 2014-03-24 2020-02-06 Bioverativ Therapeutics Inc. Lyophilized factor IX formulations
BE1025996A9 (fr) * 2018-01-19 2020-05-11 Hyloris Dev Sa Solution orale d’acide tranexamique
US10980757B2 (en) 2018-09-06 2021-04-20 RTU Pharma SA Ready-to-use tranexamic acid intravenous solution
KR20230047124A (ko) * 2020-08-10 2023-04-06 키에시 파르마슈티시 엣스. 피. 에이. 조직 플라스미노겐 활성인자 제형

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942144A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von k1k2p pro
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung

Also Published As

Publication number Publication date
PL181257B1 (pl) 2001-06-29
RU2155067C2 (ru) 2000-08-27
JP3868997B2 (ja) 2007-01-17
AU1758195A (en) 1995-09-04
SK107996A3 (en) 1997-04-09
DK0746334T3 (da) 2001-12-27
TW337997B (en) 1998-08-11
US5747030A (en) 1998-05-05
PL315978A1 (en) 1996-12-23
CZ243196A3 (en) 1997-01-15
DE4405426A1 (de) 1995-08-24
WO1995022347A1 (de) 1995-08-24
ES2162913T3 (es) 2002-01-16
EP0746334B1 (de) 2001-09-05
FI963251A0 (fi) 1996-08-20
DE59509580D1 (de) 2001-10-11
EP0746334A1 (de) 1996-12-11
MX9603515A (es) 1997-03-29
AU691881B2 (en) 1998-05-28
NZ281607A (en) 1997-04-24
ZA951371B (en) 1996-08-20
FI117925B (fi) 2007-04-30
BR9506840A (pt) 1997-10-14
HU219769B (hu) 2001-07-30
NO963460D0 (no) 1996-08-20
CA2183755A1 (en) 1995-08-24
ATE205091T1 (de) 2001-09-15
SK282827B6 (sk) 2002-12-03
CN1170591C (zh) 2004-10-13
CA2183755C (en) 2004-02-17
JPH09511495A (ja) 1997-11-18
CZ286682B6 (en) 2000-06-14
KR100356934B1 (ko) 2003-02-26
CN1141592A (zh) 1997-01-29
FI963251L (fi) 1996-08-20
HU9602284D0 (en) 1996-10-28
NO317726B1 (no) 2004-12-13
HUT74843A (en) 1997-02-28
SG50567A1 (en) 1998-07-20
KR970701059A (ko) 1997-03-17
PT746334E (pt) 2002-02-28

Similar Documents

Publication Publication Date Title
FI963251A0 (fi) Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
AU610636B2 (en) Stabilised human protein preparations
KR950703987A (ko) G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
NO954320D0 (no) Lyosfærer omfattende gonadotropin
AU6995794A (en) Aspb28 insulin crystals
DE60001914D1 (de) Mehrzweck zusammensetzungen von säuren
CA2208047A1 (en) Increasing creatine and glycogen concentration in muscle
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
AU1446488A (en) 2-hydroxy-3-aminopropionic-n,n-diacetic acid and derivatives thereof, preparation thereof, and detergents containing same
MY102929A (en) Aqueous pharmaceutical formulations of piroxicam monohydrate
ES2159938T3 (es) Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona.
DK0688226T3 (da) Proteinpræparat til forebyggelse og terapi af periodontitis eller andre bakterielle patologier i mundhulen
SE9300105D0 (sv) Stable protein solution
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
NO20003888L (no) Anti-enzympreparater omfattende etylendiamindiravsyre
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA

MM1K Lapsed by not paying the annual fees